Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of MES-1022 in healthy volunteers
NL-OMON59285Phase 1Completed
- Sponsor
- Mesentech
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in Metabolic osteopathies comparing MES-1022 with Placebo (2 arms). Started Aug 2023; status: completed.
02
Drugs
irodanoprost
03
Conditions
Metabolic osteopathies
Beyond the preview
Go deeper on NL-OMON59285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59285.